Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.

@article{Zullo2007HelicobacterPE,
  title={Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.},
  author={Angelo Zullo and Vincenzo de Francesco and G. Scaccianoce and Giampiero Manes and Cesare Efrati and Cesare Hassan and Giovanni Maconi and Donato Piglionica and Claudio Cannaviello and Carmine Panella and Sergio Morini and Enzo Ierardi},
  journal={Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver},
  year={2007},
  volume={39 9},
  pages={806-10}
}
BACKGROUND Helicobacter pylori eradication rate following standard triple therapy is decreasing worldwide. A quadruple therapy with lactoferrin and a levofloxacin-based triple therapy has been found to achieve a very high (>90%) cure rate. This study aimed to confirm these encouraging results. METHODS This was a prospective, open-label, randomised, multicentre, Italian study enrolling consecutive H. pylori infected patients. The infection at entry was assessed by endoscopy and biopsies… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…